New T-cell therapy could provide universal cancer treatment

Researchers have discovered a new type of T-cell receptor that can kill most cancer types while leaving healthy cells unharmed.

Multiple myeloma care: Taking CAR T-cell therapy for rare blood cancer to the next level, Cancer, Discovery

CAR T Cells: Second-Line Treatment Option for NHL? - NCI

Cardiff University - News, Articles, Whitepapers - Drug Target Review

Promises and challenges of adoptive T-cell therapies for solid tumours

News - Page 168 of 425 - Drug Target Review

Can a vitamin transform natural killer cells into a cancer therapy? Scientists think the answer is yes

Adoptive Cell Therapy Cancer Research Institute

News - Page 168 of 425 - Drug Target Review

CAR-T, Lifesaving Cancer Treatment, May Sometimes Cause Cancer, FDA Says - The New York Times

CAR-T cell therapy: current limitations and potential strategies

New Therapy for Leukemia and Lymphoma Patients

Frontiers Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring “Universal” Donor T Cells